Aakash Healthcare Super Speciality Hospital
Welcome,         Profile    Billing    Logout  
 0 Trials 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chopra, Pooja
BREEZE-AD-PEDS, NCT03952559 / 2018-000349-38: A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis

Active, not recruiting
3
516
Europe, Japan, RoW
Baricitinib, LY3009104, Placebo, Topical corticosteroid
Eli Lilly and Company, Incyte Corporation
Atopic Dermatitis
04/22
05/26
Budhraja, Akshay
NCT04912596: Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients With Stable Mild Asthma

Recruiting
N/A
148
RoW
Albuterol Sulfate inhalation aerosol 108 mcg per actuation, Albuterol Sulfate, Proair HFA (Albuterol Sulfate) or FDA authorized generic: Albuterol Sulfate HFA (Teva Pharmaceutical USA, Inc.) Inhalation Aerosol 108 mcg per actuation, Proair HFA or FDA authorized generic: Albuterol Sulfate HFA Inhalation Placebo, Albuterol Sulfate inhalation Placebo, Methacholine
Intech Biopharm Ltd.
Mild Asthma
03/24
04/24

Download Options